Iohexol Imax

Iohexol, the active ingredient in Iohexol Imax, is an iodinated contrast agent presented as a solution for injection for intraarterial, intrathecal, and intravenous use. It enhances radiographic visualization of vascular and tissue structures during diagnostic imaging procedures.

GNH USA supplies Iohexol Imax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres, radiology departments and clinics worldwide, delivering a quality‑assured contrast agent for routine diagnostic imaging procedures and supporting clinical research initiatives, with a focus on consistent batch integrity and regulatory compliance.

Iohexol is an iodinated contrast agent used in diagnostic imaging to improve visualization of vascular and tissue structures.

Angiography: provides enhanced vessel delineation for accurate assessment of arterial and venous anatomy. Computed tomography (CT) imaging: increases contrast between tissues, allowing better detection of lesions and anatomical detail. Myelography: improves visualization of the spinal canal and nerve roots during contrast‑enhanced radiographic examinations. Urography: enhances delineation of urinary tract structures for functional and anatomical assessment.

Adverse reactions to Iohexol may range from mild, transient symptoms to rare but serious events.

Common Side Effects: - Warm sensation: transient feeling of warmth or flushing. - Nausea: mild nausea may occur during or after injection. - Vomiting: occasional vomiting. - Headache: mild headache.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response that can be life‑threatening. - Contrast‑induced nephropathy: acute kidney injury, especially in patients with pre‑existing renal impairment. - Cardiovascular collapse: sudden drop in blood pressure or cardiac arrest.

Prior to administering Iohexol, clinicians should observe several precautionary measures to minimize risk.

Renal function assessment: evaluate baseline kidney function (eGFR) before use. Hydration status: ensure adequate patient hydration to reduce risk of contrast‑induced nephropathy. Allergy history: screen for previous reactions to iodine‑based contrast media. Thyroid disease: consider potential iodine load in patients with hyperthyroidism or thyroid disorders. Pregnancy and lactation: use only when clearly indicated, weighing potential fetal or infant exposure. Store below 25°C: keep in original container, protect from light and moisture.

Iohexol may interact with certain medicines, influencing safety or efficacy.

Major Interactions (Avoid): - Nephrotoxic agents: concurrent use of aminoglycosides, NSAIDs or amphotericin B can increase risk of renal injury. - Metformin: may need temporary discontinuation in patients with reduced renal function to prevent lactic acidosis. - Iodine‑containing drugs: amiodarone, thyroid hormone preparations can augment iodine load and affect thyroid function.

Moderate Interactions (Monitor Closely): - Diuretics: may alter fluid balance and affect contrast clearance. - Beta‑blockers: can mask early signs of anaphylactoid reactions. - Radiopharmaceuticals: timing should be coordinated to avoid overlapping imaging studies.